Business Wire

AV’s JUMP 20 Selected by Danish Defence Acquisition and Logistics Organisation for Tactical UAS Program of Record

Share

AeroVironment (AV), through its wholly owned subsidiary Arcturus UAV, has been awarded a contract by the Danish Defence Acquisition and Logistics Organisation (DALO) with a contract ceiling value of $181 million to deliver the JUMP® 20 medium uncrewed aircraft system (UAS) to the Danish Armed Forces. This 10-year program of record will equip the Danish Army with JUMP 20 systems to enhance intelligence, surveillance, and reconnaissance (ISR) operations, reinforcing AV’s position as a global leader in advanced autonomous solutions.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250210680163/en/

null

AV to supply its JUMP 20 uncrewed aircraft system to the Danish Armed Forces through new program of record (Photo: AeroVironment)

JUMP 20 is a vertical take-off and landing (VTOL), fixed-wing UAS with 13+ hours of endurance and an operational range of 185 km (115 mi). Runway independent, the system is easily storable and transportable, and can autonomously launch and land at speed without personnel intervention, making it ideal for on-the-move operations.

“JUMP 20 sets the standard for simplicity, modularity, and durability—critical attributes for reliable performance in the demanding Scandinavian terrain,” said Shane Hastings, AV’s vice president and general manager for Medium UAS. “With a combat-proven track record and over 300,000 operational flight hours, JUMP 20 stands as a best-in-class UAS, equipping the Danish Armed Forces with unmatched multi-mission capabilities to operate effectively in complex and austere environments.”

With a 30-pound modular payload capacity, JUMP 20 is engineered to adapt to evolving CONOPS and multi-domain mission demands. Its modular design enables the Danish Armed Forces to seamlessly integrate emerging technologies, ensuring their UAS capabilities remain at the cutting edge. As AV continues to advance its portfolio of robust and diverse autonomy solutions, JUMP 20 is perfectly positioned to scale, incorporating future hardware and software enhancements to meet the dynamic needs of modern warfare.

“This significant contract win reinforces confidence in the JUMP 20 system and underscores AV’s commitment to delivering unmatched capability, reliability, and innovation to our customers,” said Hastings. “We have a longstanding relationship with the Danish Ministry of Defence, and we’re excited to build on that foundation—collaborating with the Danish Armed Forces to enhance their UAS capabilities for years to come.”

ABOUT AEROVIRONMENT

AeroVironment (NASDAQ: AVAV) is a global leader in intelligent multi-domain robotic systems, uncrewed aircraft and ground systems, sensors, software analytics and connectivity. Headquartered in Arlington, Virginia, AeroVironment delivers actionable intelligence so our customers can proceed with certainty. For more information, visit www.avinc.com.

SAFE HARBOR STATEMENT

Certain statements in this press release may constitute "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements are made on the basis of current expectations, forecasts and assumptions that involve risks and uncertainties, including, but not limited to, economic, competitive, governmental and technological factors outside of our control, that may cause our business, strategy or actual results to differ materially from those expressed or implied. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, our ability to perform under existing contracts and obtain additional contracts; changes in the regulatory environment; the activities of competitors; failure of the markets in which we operate to grow; failure to expand into new markets; failure to develop new products or integrate new technology with current products; and general economic and business conditions in the United States and elsewhere in the world. For a further list and description of such risks and uncertainties, see the reports we file with the Securities and Exchange Commission. We do not intend, and undertake no obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250210680163/en/

null

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

KRAFTON Records All Time Highs in Sales (2.7098T KRW) and Operating Profit (1.1825T KRW) in 202411.2.2025 08:00:00 CET | Press release

Record-breaking earnings, with an average annual growth rate of sales reaching 20% over the past five yearsAims to hit 7T KRW in sales and double the corporate value by ‘securing a Big Franchise IP’Enhancing innovation in the global gaming industry via AI technology advancements KRAFTON, Inc. held an Investor Relations (IR) briefing on February 11, announcing its financial results for the fourth quarter and full year of 2024. According to consolidated financial statements under Korean International Financial Reporting Standards (K-IFRS), KRAFTON recorded 2.7098T KRW and operating profit (OP) of 1.1825T KRW for 2024, marking new all-time highs. These figures represent year-over-year (YoY) growth of 41.8% in sales and 54.0% in OP, driven by the continued expansion and sustainability of the PUBG IP, resulting in an average annual sales growth rate of 20% over the past five years. In the fourth quarter of 2024, KRAFTON recorded 617.6B KRW in sales and 215.5B KRW in OP, reflecting YoY incre

MammaPrint® Reimbursement Indication Extended in Belgium11.2.2025 08:00:00 CET | Press release

Agendia®, Inc. announced today that the National Institute for Sickness and Invalidity Insurance (INAMI-RIZIV) located in Brussels has expanded the reimbursement indication for MammaPrint® to include its use in the neoadjuvant setting, effective January 1, 2025. The genomic assay will now be available for full reimbursement for patients with HR+/HER2 negative early-stage breast cancer in both the pre- and postoperative settings, enabling testing on core needle biopsies for neoadjuvant treatment decisions—a pivotal advancement in providing patients with the personalized care they require. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250210842892/en/ (Graphic: Business Wire) "The ability to now use MammaPrint on core needle biopsy specimen in Belgium represents a significant step for personalized treatment for women battling breast cancer," said Professor Martine Piccart, Honorary Professor of Oncology at the Université Libr

EH Group Achieves ISO 9001 Certification11.2.2025 08:00:00 CET | Press release

EH Group is proud to announce that we have secured ISO 9001 granted by leading global certification body SQS. Their rigorous audit process confirmed that our development and production processes meet the highest international standard for quality management. The implementation of this standard highlights our focus on quality and continuous improvement. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250210743927/en/ EH FUEL CELLS receive ISO 9001 (Graphic: Business Wire) Standards “Preparing for ISO 9001 certification has meant involving the entire team, and going to the core of our technology development and production processes. Achieving it demonstrates that we have established robust and well-defined procedures across all our business activities,” states Danny Knippen, Safety, Reliability & Certification Engineer. “The ISO 9001 certification is an important milestone for the company and shows our commitment to delivering

Blackstone Life Sciences and Anthos Therapeutics Announce Agreement for Anthos to be Acquired by Novartis for up to $3.1 Billion11.2.2025 07:17:00 CET | Press release

Reflects the promise of the novel Factor XI inhibitor class of medicines to help prevent strokes and other conditions as well as Abelacimab’s potential to provide superior safetyCulminates growth journey as part of Blackstone Life Sciences Blackstone Life Sciences and Anthos Therapeutics, Inc. (“Anthos” or the “company”), a transformative, clinical-stage biopharmaceutical company developing innovative therapies for the treatment of cardiometabolic diseases, announced today that the company has entered into an agreement with Novartis to acquire Anthos for up to $3.1 billion. Anthos was founded by Blackstone Life Sciences and Novartis in 2019 with the exclusive global rights from Novartis to develop, manufacture, and commercialize abelacimab, a novel factor XI inhibitor that originated at Novartis, being developed to prevent stroke and systemic embolism in patients with atrial fibrillation as well as to prevent the recurrence of blood clots in patients with cancer. This press release fea

24,000 Registered Attendees Fill the Halls of Successful SPIE Photonics West 202510.2.2025 20:55:00 CET | Press release

The largest annual optics and photonics event of the year highlighted exciting new research, networking, and the latest in photonics products and industry trends SPIE, the international society for optics and photonics, registered 24,000 optics and photonics professionals from over 75countries for Photonics West, as the Society hosted the largest international annual photonics meeting at San Francisco’s Moscone Center. The dynamic week, which ran from 25 to 30 January, featured 1,588 exhibitors and 5,000 technical presentations across four focused tracks – BiOS, LASE, OPTO, Quantum West – four exhibitions, and the co-located AR | VR | MR conference. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250210056991/en/ SPIE Photonics West 2025 exhibition opens for business at San Francisco's Moscone Center. (Photo: Business Wire) “Photonics West marks the start of the optics and photonics calendar every year,” said SPIE CEO Kent Ro

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye